Success Metrics

Clinical Success Rate
90.0%

Based on 9 completed trials

Completion Rate
90%(9/10)
Active Trials
4(15%)
Results Posted
44%(4 trials)
Terminated
1(4%)

Phase Distribution

Ph phase_4
7
27%
Ph phase_3
3
12%
Ph phase_2
2
8%
Ph not_applicable
5
19%
Ph phase_1
6
23%

Phase Distribution

6

Early Stage

2

Mid Stage

10

Late Stage

Phase Distribution23 total trials
Phase 1Safety & dosage
6(26.1%)
Phase 2Efficacy & side effects
2(8.7%)
Phase 3Large-scale testing
3(13.0%)
Phase 4Post-market surveillance
7(30.4%)
N/ANon-phased studies
5(21.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

90.0%

9 of 10 finished

Non-Completion Rate

10.0%

1 ended early

Currently Active

4

trials recruiting

Total Trials

26

all time

Status Distribution
Active(11)
Completed(9)
Terminated(1)
Other(5)

Detailed Status

Completed9
Not yet recruiting6
unknown5
Recruiting4
Enrolling by invitation1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
26
Active
4
Success Rate
90.0%
Most Advanced
Phase 4

Trials by Phase

Phase 16 (26.1%)
Phase 22 (8.7%)
Phase 33 (13.0%)
Phase 47 (30.4%)
N/A5 (21.7%)

Trials by Status

completed935%
enrolling_by_invitation14%
recruiting415%
unknown519%
not_yet_recruiting623%
terminated14%

Recent Activity

Clinical Trials (26)

Showing 20 of 26 trialsScroll for more
NCT06251310Phase 1

SW-682 in Advanced Solid Tumors

Recruiting
NCT06005597Phase 3

Study of Obicetrapib & Ezetimibe Fixed Dose Combination on Top of Maximum Tolerated Lipid-Modifying Therapies

Completed
NCT05434637Not Applicable

Somatosensory Tinnitus RCT

Recruiting
NCT06767345Phase 4

Comparison of Moderate-Intensity Statin Plus Ezetimibe vs. High-Intensity Statin for Coronary Plaque Stabilization

Recruiting
NCT07147114Phase 4

Clinical Trial to Evaluate the Efficacy and Safety in Concomitant Administration of Macitentan and Dapagliflozin in Patients With Heart Failure With Mildly Reduced and Preserved Ejection Fraction (HFmrEF and HFpEF) and Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH)

Not Yet Recruiting
NCT06964217

Immediate Fracture Risk After Antihypertensive Drug Initiation

Not Yet Recruiting
NCT06767774Phase 4

Comparison of Pitavastatin Plus Ezetimibe Versus High-Intensity Statin Therapy on Risk of New-Onset Diabetes Mellitus

Recruiting
NCT06866665Not Applicable

Antithrombotic Strategy for AF Patients With High Risk CAD

Not Yet Recruiting
NCT06793306

A Study Comparing the Differences Between Young and Non-young Breast Cancer

Enrolling By Invitation
NCT06610643Not Applicable

Extended Remdesivir Infusion Combined With Nirmatrelvir/Ritonavir for Persistent SARS-CoV-2 Infection in Immunocompromised Patients

Not Yet Recruiting
NCT06558539Phase 3

Tibial Nerve Stimulation for Post-BPH Overactive Bladder

Not Yet Recruiting
NCT06417489Phase 4

Evaluation of Efficacy and Safety of Combination Therapy of Henagliflozin Proline, Retagliptin and Metformin in New Diagnosed Type 2 Diabetes Patients

Not Yet Recruiting
NCT05174156Phase 2

Study on the Biomarker of First-line Immunotherapy Combined With Chemotherapy in Advanced Esophageal Cancer

Unknown
NCT05356676Not Applicable

Progressive Cervical Isometric Exercises Versus Scapular Stabilization Exercises in Text Neck Syndrome

Unknown
NCT02982772Not Applicable

Patch Study - Intervention for HIV Positive Smokers

Completed
NCT04942301Phase 1

PK Study for Endostar Continuous Intravenous Infusion in NSCLC Patients With 1st-line Platinum Based Chemotherapy

Unknown
NCT04577027Phase 4

Effect Of Topical Prostaglandin F2α Analogs,Fractional CO2 Laser, Excimer Laser Or Their Combination In Treatment Of Vitiligo

Unknown
NCT04413734Phase 2

Combination of Anti-PD-1 Antibody and Chemotherapy for Unresectable Intrahepatic Cholangiocarcinoma

Unknown
NCT01301599Phase 4

Comparison Between Alpha Blocker Monotherapy and 5ARI Monotherapy Following Combination Therapy in Benign Prostatic Hyperplasia (BPH)

Completed
NCT03597841

Turkish Prospective Cohort Study on Carbapenem Resistant Klebsiella Pneumonia Bacteremia

Completed

Drug Details

Intervention Type
DRUG
Total Trials
26